高级检索
    黄婕, 王震. 一代和三代EGFR-TKI联合用药有效治疗携带EGFR-T790M和反式C797S的肺腺癌[J]. 循证医学, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005
    引用本文: 黄婕, 王震. 一代和三代EGFR-TKI联合用药有效治疗携带EGFR-T790M和反式C797S的肺腺癌[J]. 循证医学, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005
    shu
    HUANG Jie, WANG Zhen. Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance[J]. Journal of Evidence-Based Medicine, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005
    Citation: HUANG Jie, WANG Zhen. Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance[J]. Journal of Evidence-Based Medicine, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005
    shu

    一代和三代EGFR-TKI联合用药有效治疗携带EGFR-T790M和反式C797S的肺腺癌

    Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance

      摘要
      • HTML全文
      • 参考文献(5)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回